Literature DB >> 25932379

Recent Advances in Burkholderia mallei and B. pseudomallei Research.

Christopher L Hatcher1, Laura A Muruato2, Alfredo G Torres3.   

Abstract

Burkholderia mallei and Burkholderia pseudomallei are Gram-negative organisms, which are etiological agents of glanders and melioidosis, respectively. Although only B. pseudomallei is responsible for a significant number of human cases, both organisms are classified as Tier 1 Select Agents and their diseases lack effective diagnosis and treatment. Despite a recent resurgence in research pertaining to these organisms, there are still a number of knowledge gaps. This article summarizes the latest research progress in the fields of B. mallei and B. pseudomallei pathogenesis, vaccines, and diagnostics.

Entities:  

Keywords:  B. mallei; B. pseudomallei; Diagnostics; Glanders; Melioidosis; Pathogenesis; Vaccines

Year:  2015        PMID： 25932379      PMCID： PMC4410361          DOI： 10.1007/s40475-015-0042-2

Source DB:  PubMed          Journal:  Curr Trop Med Rep


  43 in total

Review 1.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.

Authors:  Wildaliz Nieves; Hailey Petersen; Barbara M Judy; Carla A Blumentritt; Kasi Russell-Lodrigue; Chad J Roy; Alfredo G Torres; Lisa A Morici
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

Review 3.  Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature.

Authors:  B J Currie; D A Fisher; D M Howard; J N Burrow; D Lo; S Selva-Nayagam; N M Anstey; S E Huffam; P L Snelling; P J Marks; D P Stephens; G D Lum; S P Jacups; V L Krause
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

4.  Quorum sensing: a transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei.

Authors:  Ricky L Ulrich; David Deshazer; Harry B Hines; Jeffrey A Jeddeloh
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.

Authors:  Andrew E Scott; Thomas R Laws; Riccardo V D'Elia; Margaret G M Stokes; Tannistha Nandi; E Diane Williamson; Patrick Tan; Joann L Prior; Timothy P Atkins
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

6.  Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis.

Authors:  Wen-Tyng Kang; Kumutha Malar Vellasamy; Eng-Guan Chua; Jamuna Vadivelu
Journal:  J Infect Dis       Date:  2014-08-26       Impact factor: 5.226

7.  BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei.

Authors:  Verena Hopf; André Göhler; Kristin Eske-Pogodda; Antje Bast; Ivo Steinmetz; Katrin Breitbach
Journal:  Infect Immun       Date:  2014-03-04       Impact factor: 3.441

8.  Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challenge.

Authors:  Apichaya Puangpetch; Robert Anderson; Yan Y Huang; Rojana Saengsot; Rasana W Sermswan; Surasakdi Wongratanacheewin
Journal:  Vaccine       Date:  2014-09-16       Impact factor: 3.641

Review 9.  Glanders: an overview of infection in humans.

Authors:  Kristopher E Van Zandt; Marek T Greer; H Carl Gelhaus
Journal:  Orphanet J Rare Dis       Date:  2013-09-03       Impact factor: 4.123

Review 10.  Development of Burkholderia mallei and pseudomallei vaccines.

Authors:  Ediane B Silva; Steven W Dow
Journal:  Front Cell Infect Microbiol       Date:  2013-03-11       Impact factor: 5.293
View more
  27 in total

1.  Discovery of Ubonodin, an Antimicrobial Lasso Peptide Active against Members of the Burkholderia cepacia Complex.

Authors:  Wai Ling Cheung-Lee; Madison E Parry; Chuhan Zong; Alexis Jaramillo Cartagena; Seth A Darst; Nancy D Connell; Riccardo Russo; A James Link
Journal:  Chembiochem       Date:  2020-01-03       Impact factor: 3.164

Review 2.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

3.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

4.  Vibrio cholerae VciB Mediates Iron Reduction.

Authors:  Eric D Peng; Shelley M Payne
Journal:  J Bacteriol       Date:  2017-05-25       Impact factor: 3.490

5.  Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.

Authors:  Shawn M Zimmerman; Mackenzie E Long; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Vet Pathol       Date:  2017-11-16       Impact factor: 2.221

6.  In Vitro and In Vivo Characterization of Tebipenem (TBP), an Orally Active Carbapenem, against Biothreat Pathogens.

Authors:  Nicholas P Clayton; Akash Jain; Stephanie A Halasohoris; Lisa M Pysz; Sanae Lembirik; Steven D Zumbrun; Christopher D Kane; Michael J Hackett; Denise Pfefferle; M Autumn Smiley; Michael S Anderson; Henry Heine; Gabriel T Meister; Michael J Pucci
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.191

7.  Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.

Authors:  Laura A Muruato; Daniel Tapia; Christopher L Hatcher; Mridul Kalita; Paul J Brett; Anthony E Gregory; James E Samuel; Richard W Titball; Alfredo G Torres
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

8.  Proteomic Analysis of Non-human Primate Peripheral Blood Mononuclear Cells During Burkholderia mallei Infection Reveals a Role of Ezrin in Glanders Pathogenesis.

Authors:  Chih-Yuan Chiang; Yang Zhong; Michael D Ward; Douglas J Lane; Tara Kenny; Raysa Rosario-Acevedo; Brett P Eaton; Sylvia R Treviño; Taylor B Chance; Meghan Hu; Patricia L Worsham; David M Waag; Richard T Moore; Lisa H Cazares; Christopher K Cote; Yingyao Zhou; Rekha G Panchal
Journal:  Front Microbiol       Date:  2021-04-22       Impact factor: 5.640

Review 9.  Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

Authors:  Gonzalo A Pradenas; Brittany N Ross; Alfredo G Torres
Journal:  Vaccines (Basel)       Date:  2016-04-15

10.  DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.

Authors:  Vesna Memišević; Kamal Kumar; Nela Zavaljevski; David DeShazer; Anders Wallqvist; Jaques Reifman
Journal:  BMC Bioinformatics       Date:  2016-09-20       Impact factor: 3.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.